Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M05BA07	APO-RISEDRONATE	G	Risedronate sodium - 150mg	150mg	Tablet	1,034,759 L.L
C10AA07	APO-ROSUVASTATIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	670,577 L.L
C10AA07	APO-ROSUVASTATIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	670,577 L.L
C10AA07	APO-ROSUVASTATIN	G	Rosuvastatin (calcium) - 40mg	40mg	Tablet	670,577 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
R03AC02	ASTHALIN	G	Salbutamol (sulfate) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	325,210 L.L
R03AC02	ASMALAT	G	Salbutamol (sulfate) - 2mg/5ml	2mg/5ml	Syrup	177,899 L.L
R03AK13	AEROCORT-A HFA	G	Salbutamol - 100mcg/dose, Beclometasone - 50mcg/dose		Metered dose inhaler	541,569 L.L
G04BD08	ASOLFENA	G	Solifenacin succinate - 10mg	10mg	Tablet, film coated	971,598 L.L
G04BD08	ASOLFENA	G	Solifenacin succinate - 5mg	5mg	Tablet, film coated	971,598 L.L
C03DA01	ALDACTONE	B	Spironolactone - 100mg	100mg	Tablet	458,250 L.L
C03DA01	ALDACTONE	B	Spironolactone - 25mg	25mg	Tablet	237,860 L.L
R05X	ACTISOUFRE	B	Sulfure de Sodium - 13mg, Saccharomyces Cerevisiae - 500mg		Solution	740,457 L.L
B01AB11	ANGIOFLUX	G	Sulodexide - 250LRU	250LRU	Capsule, soft	2,026,514 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 0.5mg	0.5mg	Capsule, prolonged release	13,297,758 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 1mg	1mg	Capsule, prolonged release	L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 1mg	1mg	Capsule, prolonged release	25,729,044 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	68,645,618 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 5mg	5mg	Capsule, prolonged release	85,485,667 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 10mg	10mg	Tablet	888,280 L.L
G04BE08	AMOS	G	Tadalafil - 10mg	10mg	Film, orodispersible	1,662,781 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 20mg	20mg	Tablet	1,111,358 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 5mg	5mg	Tablet	1,635,456 L.L
G04BE08	AMOS	G	Tadalafil - 5mg	5mg	Film, orodispersible	2,743,998 L.L
G04CA02	APO-TAMSULOSIN CR	G	Tamsulosin HCl - 0.4mg	0.4mg	Tablet	607,417 L.L
C09CA07	ARBIVASTEL	G	Telmisartan - 80mg	80mg	Tablet	667,890 L.L
D01BA02	APO-TERBINAFINE	G	Terbinafine HCl - 250mg	250mg	Tablet	1,409,691 L.L
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	38,773,533 L.L

...